Circ_0016347 modulates proliferation, migration, invasion, cell cycle, and apoptosis of osteosarcoma cells via the miR-661/IL6R axis

References

• Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320–vii325.
   PubMed Web of Science ®Google Scholar
• Kansara M, Teng MW, Smyth MJ, et al. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14(11):722–735.
   PubMed Web of Science ®Google Scholar
• Marina N, Gebhardt M, Teot L, et al. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9(4):422–441.
   PubMed Web of Science ®Google Scholar
• Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309–316.
   PubMed Web of Science ®Google Scholar
• He J, Xie Q, Xu H, et al. Circular RNAs and cancer. Cancer Lett. 2017;396:138–144.
   PubMed Web of Science ®Google Scholar
• Xi Y, Fowdur M, Liu Y, et al. Differential expression and bioinformatics analysis of circRNA in osteosarcoma. Biosci Rep. 2019;39:BSR20181514.
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Xu D, et al. An update on the roles of circular RNAs in osteosarcoma. Cell Prolif. 2021;54(1):e12936.
   PubMed Web of Science ®Google Scholar
• Xu TT, Zhang Y, He JY, et al. Bajijiasu ameliorates β-amyloid-triggered endoplasmic reticulum stress and related pathologies in an Alzheimer's disease model. Cell Physiol Biochem. 2018;46(1):107–117.
   PubMedGoogle Scholar
• Chen J, Liu G, Wu Y, et al. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling. Mol Cancer. 2019;18(1):150.
   PubMed Web of Science ®Google Scholar
• Li Z, Fu Y, Ouyang W, et al. Circ_0016347 promotes osteosarcoma progression by regulating miR-1225-3p/KCNH1 axis. Cancer Biother Radiopharm. 2021.
   Web of Science ®Google Scholar
• Jin H, Jin X, Zhang H, et al. Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells. Oncotarget. 2017;8(15):25571–25581.
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• Giordano L, Porta GD, Peretti GM, et al. Therapeutic potential of microRNA in tendon injuries. Br Med Bull. 2020;133(1):79–94.
   PubMed Web of Science ®Google Scholar
• Oliviero A, Della Porta G, Peretti GM, et al. MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Br Med Bull. 2019;130(1):137–147.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Q, Wang Y, et al. Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway. Biochem Biophys Res Commun. 2018;505(4):996–1002.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu YH, Diao HY, et al. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem Biophys Res Commun. 2015;468(4):870–876.
   PubMed Web of Science ®Google Scholar
• Liu F, Cai Y, Rong X, et al. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non-small cell lung cancer. Mol Cancer. 2017;16(1):122.
   PubMedGoogle Scholar
• Zhu T, Yuan J, Wang Y, et al. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. Biomed Pharmacother. 2015;75:123–128.
   PubMed Web of Science ®Google Scholar
• Taher MY, Davies DM, Maher J. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer. Biochem Soc Trans. 2018;46(6):1449–1462.
   PubMedGoogle Scholar
• Edwardson DW, Parissenti AM, Kovala AT. Chemotherapy and inflammatory cytokine signalling in cancer cells and the tumour microenvironment. Adv Exp Med Biol. 2019;1152:173–215.
   PubMed Web of Science ®Google Scholar
• Oner MG, Rokavec M, Kaller M, et al. Combined inactivation of TP53 and MIR34A promotes colorectal cancer development and progression in mice via increasing levels of IL6R and PAI1. Gastroenterology. 2018;155(6):1868–1882.
   PubMed Web of Science ®Google Scholar
• Yin Y, Yao S, Hu Y, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23(23):7375–7387.
   PubMed Web of Science ®Google Scholar
• Mulder DJ, Pacheco I, Hurlbut DJ, et al. FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut. 2009;58(2):166–173.
   PubMed Web of Science ®Google Scholar
• Yan J, Wang Q, Zou K, et al. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma. Mol Med Rep. 2015;12(1):498–502.
   PubMed Web of Science ®Google Scholar
• Ge X, Liu W, Zhao W, et al. Exosomal transfer of LCP1 promotes osteosarcoma cell tumorigenesis and metastasis by activating the JAK2/STAT3 signaling pathway. Mol Ther Nucleic Acids. 2020;21:900–915.
   PubMedGoogle Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79.
   PubMed Web of Science ®Google Scholar
• Wu X, Chen Z, Zeng W, et al. Silencing of Eag1 gene inhibits osteosarcoma proliferation and migration by targeting STAT3-VEGF pathway. Biomed Res Int. 2015;2015:617316.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhong D, Gao Q, et al. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression. Int J Med Sci. 2013;10(6):676–682.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhong D, Fu X, et al. Silencing of ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression . Int J Mol Sci. 2014;15(4):5570–5581.
   PubMedGoogle Scholar
• Fan L, Zhu C, Qiu R, et al. MicroRNA-661 enhances TRAIL or STS induced osteosarcoma cell apoptosis by modulating the expression of cytochrome c1. Cell Physiol Biochem. 2017;41(5):1935–1946.
   PubMedGoogle Scholar
• Wang W, Yuan X, Xu A, et al. Human cancer cells suppress behaviors of endothelial progenitor cells through miR-21 targeting IL6R. Microvasc Res. 2018;120:21–28.
   PubMed Web of Science ®Google Scholar
• Rokavec M, Oner MG, Li H, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest. 2014;124(4):1853–1867.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ding L, Hu Q, et al. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis. Mol Cancer. 2017;16(1):141.
   PubMedGoogle Scholar
• Deng N, Li L, Gao J, et al. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma. Biochem Biophys Res Commun. 2018;495(1):189–196.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yu L, Han N, et al. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the jak-stat signaling pathway. Biomed Pharmacother. 2018;107:270–282.
   PubMed Web of Science ®Google Scholar
• Liu SY, Deng SY, He YB, et al. miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R. Biochem Biophys Res Commun. 2017;482(4):987–993.
   PubMed Web of Science ®Google Scholar
• Garbers C, Aparicio-Siegmund S, Rose-John S. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Curr Opin Immunol. 2015;34:75–82.
   PubMed Web of Science ®Google Scholar
• Lei Z, Duan H, Zhao T, et al. PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway. Cell Death Dis. 2018;9(3):375.
   PubMedGoogle Scholar
• Chen J, Chen Z. Downregulation of miR-19a inhibits the proliferation and promotes the apoptosis of osteosarcoma cells by regulating the JAK2/STAT3 pathway. Oncol Lett. 2020;20(5):1.
   PubMed Web of Science ®Google Scholar
• Huang L, Huang Z, Lin W, et al. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway. Int J Oncol. 2019;54(6):1969–1980.
   PubMed Web of Science ®Google Scholar
• Deng S, Wang A, Chen X, et al. HBD inhibits the development of colitis-associated cancer in mice via the IL-6R/STAT3 signaling pathway. IJMS. 2019;20(5):1069.
   Google Scholar
• Sun C, Yang J, Cheng HB, et al. 2-Hydroxy-3-methylanthraquinone inhibits lung carcinoma cells through modulation of IL-6-induced JAK2/STAT3 pathway. Phytomedicine. 2019;61:152848.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang A, Xiang J, et al. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep. 2016;36(3):1385–1392.
   PubMed Web of Science ®Google Scholar
• Kampan NC, Xiang SD, McNally OM, et al. Immunotherapeutic interleukin-6 or interleukin-6 receptor blockade in cancer: challenges and opportunities. Curr Med Chem. 2018;25(36):4785–4806.
   PubMed Web of Science ®Google Scholar
• Gargano G, Oliviero A, Oliva F, et al. Small interfering RNAs in tendon homeostasis. Br Med Bull. 2021;138(1):58–67.
   PubMed Web of Science ®Google Scholar